Maxcyte shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Maxcyte
Tip: Access up to 7 years of quarterly data
All positions including Maxcyte held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Maxcyte by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $35k | 7.4k | 4.70 |
| 2023-09-30 | $23k | 7.4k | 3.12 |
| 2023-06-30 | $34k | 7.4k | 4.59 |
| 2023-03-31 | $37k | 7.4k | 4.95 |
| 2022-12-31 | $41k | 7.4k | 5.48 |
| 2022-09-30 | $48k | 7.4k | 6.47 |
| 2022-06-30 | $35k | 7.4k | 4.72 |
| 2022-03-31 | $52k | 7.4k | 7.01 |
| 2021-12-31 | $76k | 7.4k | 10.25 |
| 2021-09-30 | $15k | 1.2k | 12.49 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors